Predicting the gastrointestinal bleeding of HBV-related acute-on-chronic liver failure based on machine learning.

Background: This study aimed to investigate the effect of gastrointestinal bleeding (GIB) on the short-term survival of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) patients, establish a prediction model for HBV-ACLF-related GIB via machine learning (ML) algorithms, and compare the predictive ability of various models. Methods: A total of 583 HBV-ACLF patients from two medical centers were retrospectively enrolled, and patients from one of the centers were randomly divided into a training cohort ( Results: In the training cohort, patients in the GIB group had significantly lower 30- and 90-day survival rates than did those in the NGIB group (48.72% versus 85.67% and 10.26% versus 64.80%, respectively), and similar results were obtained in the test cohort and the validation cohort. LASSO regression screened seven features associated with GIB, of which portal hypertension, electrolyte disturbance, and white blood cell counts were modeled features common to the five machine prediction models. The AUCs of the LR, SVM, DT, RF, and KNN models in the training cohort were 0.819, 0.924, 0.661, 1.000, and 0.865, respectively. Compared with the other four models, the LR model had the lowest PPV of 0.202 in the test cohort, the SVM model had the lowest AUC and sensitivity of 0.657 and 0.500 in the validation cohort, the DT model had the lowest sensitivity of 0.436 and 0.438 in the training and test cohorts, respectively, and the KNN model had the lowest PPV of 0.250 in the validation cohort. Notably, the RF model had the least fluctuations in accuracy, AUC, sensitivity, specificity, PPV, and NPV among the 3 cohorts, with good overall predictive ability. Conclusion: GIB has a significant effect on short-term survival in patients with HBV-ACLF. On this basis, five ML prediction models, LR, SVM, DT, RF, and KNN, were established to have better prediction ability for GIB, among which the RF model has the most robust prediction performance, which can help clinicians intervene in advance and improve the short-term survival rate of patients.